Literature DB >> 25998209

Phosphorylation of the nuclear receptor corepressor 1 by protein kinase B switches its corepressor targets in the liver in mice.

Young Suk Jo1,2, Dongryeol Ryu1, Adriano Maida1, Xu Wang1, Ronald M Evans3, Kristina Schoonjans4, Johan Auwerx1.   

Abstract

UNLABELLED: Nuclear receptor corepressor 1 (NCoR1) is a transcriptional coregulator that has wide-ranging effects on gene expression patterns. In the liver, NCoR1 represses lipid synthesis in the fasting state, whereas it inhibits activation of peroxisome proliferator-activated receptor alpha (PPARα) upon feeding, thereby blunting ketogenesis. Here, we show that insulin by activation of protein kinase B induces phosphorylation of NCoR1 on serine 1460, which selectively favors its interaction with PPARα and estrogen-related receptor alpha (ERRα) over liver X receptor alpha (LXRα). Phosphorylation of NCoR1 on S1460 selectively derepresses LXRα target genes, resulting in increased lipogenesis, whereas, at the same time, it inhibits PPARα and ERRα targets, thereby attenuating oxidative metabolism in the liver. Phosphorylation-gated differential recruitment of NCoR1 to different nuclear receptors explains the apparent paradox that liver-specific deletion of NCoR1 concurrently induces both lipogenesis and oxidative metabolism owing to a global derepression of LXRα, PPARα, and ERRα activity.
CONCLUSION: Phosphorylation-mediated recruitment switch of NCoR1 between nuclear receptor subsets provides a mechanism by which corepressors can selectively modulate liver energy metabolism during the fasting-feeding transition.
© 2015 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25998209      PMCID: PMC4618256          DOI: 10.1002/hep.27907

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  50 in total

1.  A tissue-specific atlas of mouse protein phosphorylation and expression.

Authors:  Edward L Huttlin; Mark P Jedrychowski; Joshua E Elias; Tapasree Goswami; Ramin Rad; Sean A Beausoleil; Judit Villén; Wilhelm Haas; Mathew E Sowa; Steven P Gygi
Journal:  Cell       Date:  2010-12-23       Impact factor: 41.582

2.  Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways.

Authors:  Jessica L Yecies; Hui H Zhang; Suchithra Menon; Sihao Liu; Derek Yecies; Alex I Lipovsky; Cem Gorgun; David J Kwiatkowski; Gökhan S Hotamisligil; Chih-Hao Lee; Brendan D Manning
Journal:  Cell Metab       Date:  2011-07-06       Impact factor: 27.287

3.  S6 kinase 2 deficiency enhances ketone body production and increases peroxisome proliferator-activated receptor alpha activity in the liver.

Authors:  Kyeongjin Kim; Suhkneung Pyo; Sung Hee Um
Journal:  Hepatology       Date:  2012-03-08       Impact factor: 17.425

4.  mTORC1 controls fasting-induced ketogenesis and its modulation by ageing.

Authors:  Shomit Sengupta; Timothy R Peterson; Mathieu Laplante; Stephanie Oh; David M Sabatini
Journal:  Nature       Date:  2010-12-23       Impact factor: 49.962

5.  Genome-wide profiling of liver X receptor, retinoid X receptor, and peroxisome proliferator-activated receptor α in mouse liver reveals extensive sharing of binding sites.

Authors:  Michael Boergesen; Thomas Åskov Pedersen; Barbara Gross; Simon J van Heeringen; Dik Hagenbeek; Christian Bindesbøll; Sandrine Caron; Fanny Lalloyer; Knut R Steffensen; Hilde I Nebb; Jan-Åke Gustafsson; Hendrik G Stunnenberg; Bart Staels; Susanne Mandrup
Journal:  Mol Cell Biol       Date:  2011-12-12       Impact factor: 4.272

Review 6.  International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.

Authors:  Liliane Michalik; Johan Auwerx; Joel P Berger; V Krishna Chatterjee; Christopher K Glass; Frank J Gonzalez; Paul A Grimaldi; Takashi Kadowaki; Mitchell A Lazar; Stephen O'Rahilly; Colin N A Palmer; Jorge Plutzky; Janardan K Reddy; Bruce M Spiegelman; Bart Staels; Walter Wahli
Journal:  Pharmacol Rev       Date:  2006-12       Impact factor: 25.468

Review 7.  Deconstructing repression: evolving models of co-repressor action.

Authors:  Valentina Perissi; Kristen Jepsen; Christopher K Glass; Michael G Rosenfeld
Journal:  Nat Rev Genet       Date:  2010-02       Impact factor: 53.242

8.  The nuclear corepressor, NCoR, regulates thyroid hormone action in vivo.

Authors:  Inna Astapova; Larissa J Lee; Crystal Morales; Stefanie Tauber; Martin Bilban; Anthony N Hollenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-03       Impact factor: 11.205

Review 9.  ERRalpha: a metabolic function for the oldest orphan.

Authors:  Josep A Villena; Anastasia Kralli
Journal:  Trends Endocrinol Metab       Date:  2008-09-06       Impact factor: 12.015

10.  NCoR1 is a conserved physiological modulator of muscle mass and oxidative function.

Authors:  Hiroyasu Yamamoto; Evan G Williams; Laurent Mouchiroud; Carles Cantó; Weiwei Fan; Michael Downes; Christophe Héligon; Grant D Barish; Béatrice Desvergne; Ronald M Evans; Kristina Schoonjans; Johan Auwerx
Journal:  Cell       Date:  2011-11-11       Impact factor: 41.582

View more
  20 in total

Review 1.  Protein acetylation in metabolism - metabolites and cofactors.

Authors:  Keir J Menzies; Hongbo Zhang; Elena Katsyuba; Johan Auwerx
Journal:  Nat Rev Endocrinol       Date:  2015-10-27       Impact factor: 43.330

Review 2.  Endocrine-disrupting chemicals and fatty liver disease.

Authors:  Charles E Foulds; Lindsey S Treviño; Brian York; Cheryl L Walker
Journal:  Nat Rev Endocrinol       Date:  2017-05-19       Impact factor: 43.330

3.  Humanized UGT1 Mice, Regulation of UGT1A1, and the Role of the Intestinal Tract in Neonatal Hyperbilirubinemia and Breast Milk-Induced Jaundice.

Authors:  Shujuan Chen; Robert H Tukey
Journal:  Drug Metab Dispos       Date:  2018-08-09       Impact factor: 3.922

4.  Intestinal NCoR1, a regulator of epithelial cell maturation, controls neonatal hyperbilirubinemia.

Authors:  Shujuan Chen; Wenqi Lu; Mei-Fei Yueh; Eva Rettenmeier; Miao Liu; Miles Paszek; Johan Auwerx; Ruth T Yu; Ronald M Evans; Kepeng Wang; Michael Karin; Robert H Tukey
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-06       Impact factor: 11.205

Review 5.  Transcriptional control of energy metabolism by nuclear receptors.

Authors:  Charlotte Scholtes; Vincent Giguère
Journal:  Nat Rev Mol Cell Biol       Date:  2022-05-16       Impact factor: 113.915

Review 6.  Gene-Specific Actions of Transcriptional Coregulators Facilitate Physiological Plasticity: Evidence for a Physiological Coregulator Code.

Authors:  Michael R Stallcup; Coralie Poulard
Journal:  Trends Biochem Sci       Date:  2020-03-13       Impact factor: 13.807

7.  Macrophage Nuclear Receptor Corepressor 1 Deficiency Protects Against Ischemic Stroke in Mice.

Authors:  Shuai Shao; Yan-Lin Chen; Lin-Juan Du; Yuan Liu; Hong Zhu; Lu-Jun Zhou; Ting Liu; Wen-Zhen Lin; Fei Yu; Xiao-Xin Ma; Xue-Rui Shi; Xiao-Qian Meng; Yan Liu; Yong-Li Wang; Lan Bai; Xiao-Hua Zhang; Feng Jia; Sheng-Zhong Duan
Journal:  J Cardiovasc Transl Res       Date:  2022-01-17       Impact factor: 4.132

8.  Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice.

Authors:  Karim Gariani; Keir J Menzies; Dongryeol Ryu; Casey J Wegner; Xu Wang; Eduardo R Ropelle; Norman Moullan; Hongbo Zhang; Alessia Perino; Vera Lemos; Bohkyung Kim; Young-Ki Park; Alessandra Piersigilli; Tho X Pham; Yue Yang; Chai Siah Ku; Sung I Koo; Anna Fomitchova; Carlos Cantó; Kristina Schoonjans; Anthony A Sauve; Ji-Young Lee; Johan Auwerx
Journal:  Hepatology       Date:  2015-12-16       Impact factor: 17.425

9.  Regulation of Intestinal UDP-Glucuronosyltransferase 1A1 by the Farnesoid X Receptor Agonist Obeticholic Acid Is Controlled by Constitutive Androstane Receptor through Intestinal Maturation.

Authors:  André A Weber; Elvira Mennillo; Xiaojing Yang; Lori W E van der Schoor; Johan W Jonker; Shujuan Chen; Robert H Tukey
Journal:  Drug Metab Dispos       Date:  2020-11-05       Impact factor: 3.922

10.  Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD.

Authors:  Alexandra Montagner; Arnaud Polizzi; Edwin Fouché; Simon Ducheix; Yannick Lippi; Frédéric Lasserre; Valentin Barquissau; Marion Régnier; Céline Lukowicz; Fadila Benhamed; Alison Iroz; Justine Bertrand-Michel; Talal Al Saati; Patricia Cano; Laila Mselli-Lakhal; Gilles Mithieux; Fabienne Rajas; Sandrine Lagarrigue; Thierry Pineau; Nicolas Loiseau; Catherine Postic; Dominique Langin; Walter Wahli; Hervé Guillou
Journal:  Gut       Date:  2016-02-01       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.